Using phenotypic information of anticancer compounds used in Ayurveda, Fauzi et al. (2012) predicted ten most enriched targets through in silico target prediction method that include primary targets involved in cancer progression such as PTP1B and T-cell Protein Tyrosine Phosphatase (TC-TCP) and synergistic targets such as efflux pumps, P-glycoprotein, opening new avenues for Ayurvedic drug research [57]. Here, PTPN2 is linked to cancer.